NASDAQ:AXGN - Nasdaq - US05463X1063 - Common Stock - Currency: USD
Taking everything into account, AXGN scores 4 out of 10 in our fundamental rating. AXGN was compared to 188 industry peers in the Health Care Equipment & Supplies industry. AXGN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AXGN has a correct valuation and a medium growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -3.65% | ||
ROE | -6.8% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 74.18% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.45 | ||
Debt/FCF | N/A | ||
Altman-Z | 2.6 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 4.28 | ||
Quick Ratio | 2.65 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 64.06 | ||
Fwd PE | 22.48 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | 69.69 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
10.89
-0.01 (-0.09%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 64.06 | ||
Fwd PE | 22.48 | ||
P/S | 2.55 | ||
P/FCF | N/A | ||
P/OCF | 136.92 | ||
P/B | 4.71 | ||
P/tB | 4.99 | ||
EV/EBITDA | 69.69 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -3.65% | ||
ROE | -6.8% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 74.18% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.45 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | 6.42 | ||
Cap/Depr | 49.14% | ||
Cap/Sales | 1.98% | ||
Interest Coverage | N/A | ||
Cash Conversion | 48.72% | ||
Profit Quality | N/A | ||
Current Ratio | 4.28 | ||
Quick Ratio | 2.65 | ||
Altman-Z | 2.6 |